Artwork for podcast Febrile
125: A Critical Query
Episode 12517th November 2025 • Febrile • Sara Dong
00:00:00 00:42:17

Share Episode

Shownotes

A team from Sultan Qaboos University Hospital in Muscat, Oman joins Febrile to share a case of a critically ill child who arrives in the emergency department with fever. Listen in as Drs. Raghad Al-abdwani, Badriya Al Adawi, and Zaid Al Hinai walk through the case from the pediatric critical care, infectious diseases, and microbiology perspectives!

Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com

Febrile is produced with support from the Infectious Diseases Society of America (IDSA)

Transcripts

Speaker:

Hi everyone.

Speaker:

Welcome to Febrile, a cultured podcast about all things infectious disease.

Speaker:

We use consult questions to dive into ID clinical reasoning, diagnostics

Speaker:

and antimicrobial management.

Speaker:

I'm Sara Dong, your host and a Med Peds ID doc.

Speaker:

Today we are joined by a team from Sultan Qaboos University in Muscat, Oman.

Speaker:

First up, I'll introduce Dr. Raghad Al-abdwani, who is a Senior

Speaker:

Consultant and the Head of the Pediatric Intensive Care Unit.

Speaker:

Hi, it's Raghad.

Speaker:

Thank you very much for having us here today.

Speaker:

Next we have Dr. Badriya Al Adawi, who is a medical microbiologist.

Speaker:

Hi, this is Badriya, thank you for having us today.

Speaker:

And rounding out our team, we have Dr. Zaid Al Hinai.

Speaker:

Zaid serves currently as the Head of the Pediatric ID Unit

Speaker:

at the Child Health Department.

Speaker:

This is Zaid.

Speaker:

Thank you for hosting us.

Speaker:

All right.

Speaker:

So as everyone's favorite cultured podcast, we always like to start by

Speaker:

asking if folks would share a little piece of culture, really just something

Speaker:

non-medical that brings you happiness.

Speaker:

So I have a particular knack or interest in hiking, trekking, abseiling.

Speaker:

And though I've done a number of international tracks, like, uh, Machu

Speaker:

Picchu, Kilimanjaro, Everest Base Camp, but, Oman itself offers a lot of really

Speaker:

beautiful mountains and caves and a number of very challenging canyons.

Speaker:

So sometimes people ask me like, don't you get enough adrenaline, uh, in the PICU?

Speaker:

But I always say to them that the adrenaline in these

Speaker:

adventures are quite different.

Speaker:

And I see it as a way to help in like, um, you know, pressing the reset button.

Speaker:

Love it.

Speaker:

I don't know, I feel like the, um, the extreme hiking and PICU in

Speaker:

my mind goes together perfectly.

Speaker:

It does.

Speaker:

It kind, it balances each other how I see it.

Speaker:

Um, so for me, I enjoy going back to my hometown Nizwa and, uh, a few

Speaker:

months ago, I went with my kids and we went to the fort, the Fort of Nizwa.

Speaker:

And it was an amazing feeling.

Speaker:

I haven't been there for a very long time, so just walking around with

Speaker:

my kids, it was just like, really, I cannot describe the feeling.

Speaker:

It felt like I went into a time machine with my kids and went, went to the past.

Speaker:

So it was really, really great.

Speaker:

That's lovely.

Speaker:

Mm.

Speaker:

Okay.

Speaker:

Uh, for me, actually, one thing that's really nice about living

Speaker:

in the Middle East is the food.

Speaker:

There is like this really ancient recipes that have been perfected

Speaker:

over like thousands of years.

Speaker:

And so, uh, I really enjoy learning some of these really old recipes.

Speaker:

Like ones my grandmother would, would have made.

Speaker:

I did learn, actually, one of the Middle Eastern recipes is a Palestinian

Speaker:

recipe called, uh, musakhan.

Speaker:

Musakhan in Arabic just means something that's warmed up or cooked.

Speaker:

This one is really uniquely Palestinian and it's got this, uh, unique

Speaker:

ingredients, onions and chicken.

Speaker:

Not, not very unique, but then they put sumac, which is a very,

Speaker:

uh, unique Middle Eastern, like, kind of, uh, tangy, a sour spice.

Speaker:

And, uh, I, I learned how to make it, and they make it usually with bread.

Speaker:

And knowing me, like I always like to put a twist on things.

Speaker:

So what I did is I made it in a pie.

Speaker:

And that's from my years in America, put all this chicken into

Speaker:

a pie and it came out really good.

Speaker:

I had good beginners luck on that.

Speaker:

You're going to have to share that with us Zaid!

Speaker:

that sounds really good.

Speaker:

Well, I think I've, I think I've told people on the podcast before, but, um, I

Speaker:

love cooking and learning about cooking.

Speaker:

And I originally wanted to find some way to tie it in where people

Speaker:

brought a recipe or a dish that they like to just talk about.

Speaker:

Um, but I couldn't find something clever to tie them together.

Speaker:

But I still have a special place in my heart for when people bring recipe or

Speaker:

food related things as their culture.

Speaker:

Well, we have a very interesting case today.

Speaker:

I think Raghad is gonna, um, introduce us to the patient

Speaker:

who's shown up in the hospital.

Speaker:

Yeah, so we started off with a PICU team visiting the emergency department.

Speaker:

Uh, we went to see a 4-year-old boy with sickle cell disease, Hemoglobin

Speaker:

SS, on hydroxyurea and he had presented to the emergency department with a five

Speaker:

day history of fever and fatigue, which was just getting worse over the days.

Speaker:

He even then started having significant abdominal pain.

Speaker:

He vomited a couple of times and he was looking quite pale to the parents.

Speaker:

And even had a yellowish discoloration as they described.

Speaker:

So they took him to the local health center just a day prior to

Speaker:

presenting to us, and they did a CBC at that time, which showed that the

Speaker:

hemoglobin was 5.4 grams per deciliter.

Speaker:

So basically much lower than his baseline, which is about eight

Speaker:

or nine grams per deciliter.

Speaker:

So in the emergency department, um, the child appeared quite pale.

Speaker:

He was jaundiced and drowsy.

Speaker:

He was quite tachycardic with heart rates in the 160s, tachypneic and

Speaker:

desaturating with sats of 85% in room air.

Speaker:

But with giving him supplemental oxygen, it was above 95%.

Speaker:

What was striking is that he was extremely cold to touch and he had

Speaker:

poor peripheral pulses and delayed capillary refill of about five seconds,

Speaker:

but his blood pressure was actually normal, normal high, even 120/70.

Speaker:

So when examined his chest, he had a hyperdynamic precordium and he

Speaker:

had an ejection systolic murmur at the apex, but good air entry

Speaker:

bilaterally with no added sounds.

Speaker:

His abdomen was very, very distended and it revealed also a very

Speaker:

tender big liver, palpable at 15 centimeters below the costal margin.

Speaker:

But we couldn't palpate, uh, spleen, which is, you know, what

Speaker:

we tend to see in those patients.

Speaker:

Um, he was drowsy and irritable, but he didn't have any meningeal signs and he

Speaker:

had no apparent focal neurologic deficits.

Speaker:

We examined his ears, his nose, and his throat, and they were unremarkable.

Speaker:

Now in the emergency department, we have access to a blood gas machine.

Speaker:

So we did a venous blood gas, which showed that he had severe anemia

Speaker:

with a hemoglobin of 2.3, and he had severe lactic metabolic acidosis.

Speaker:

So his pH was 7.05.

Speaker:

His bicarb was seven with a base deficit of 15, and his lactate

Speaker:

was 22 milli moles per liter.

Speaker:

So taking all that into consideration our impressions that we've got a 4-year-old

Speaker:

boy with sickle cell disease and he had shock and take into consideration that

Speaker:

these kids are prone to encapsulated organisms, and the fever, you know,

Speaker:

we thought along the lines of septic shock, and likely a sequestration

Speaker:

because of the severe anemia plus minus a sickle cell, uh, crisis.

Speaker:

And of course, we were yet to look for evidence of multi-organ dysfunction.

Speaker:

So just a little about his past medical history.

Speaker:

As I mentioned, his sickle cell disease, and he had history of previous

Speaker:

admissions because of vaso-occlusive crises and needs for blood transfusion.

Speaker:

But in the past, one year after starting hydroxyurea, the frequency

Speaker:

of his admissions were much less.

Speaker:

So Zaid, now with all the above, are there any other additional information that

Speaker:

you'd like to know about the patient?

Speaker:

Yeah.

Speaker:

So it sounds like the child is in the critical condition, septic shock.

Speaker:

There's some liver involvement.

Speaker:

You guys did a great job to look at a lot of the uh, systems that could be involved.

Speaker:

Uh, we also would like to know a little bit if there's any skin manifestations

Speaker:

or joint manifestations in this child.

Speaker:

Uh, from the ID point of view, we always like to ask about

Speaker:

exposure history, very important.

Speaker:

So, where does he live?

Speaker:

What kind of setting?

Speaker:

Was there anybody sick that he could have uh, been in contact with?

Speaker:

Did he travel anywhere?

Speaker:

Uh, does he, do they have any pets?

Speaker:

Do they, uh, go to any farms?

Speaker:

Is there any other animal exposure?

Speaker:

Do they consume un pasteurized dairy products or undercooked meat?

Speaker:

Is there anybody with tuberculosis potentially?

Speaker:

And did he have any insect bites or tick bites or mosquito bites?

Speaker:

And did he go swimming anywhere?

Speaker:

What is the water source?

Speaker:

Mm-hmm.

Speaker:

So, you know, it's interesting you mentioned that 'cause we did notice

Speaker:

at that time that, you know, he had these multiple round hyper pigment,

Speaker:

hyperpigmented macular rashes of about, I would say, two to three centimeters in

Speaker:

diameter in his upper, but especially in his lower extremities, especially like in

Speaker:

the pretibial, the bony prominences areas.

Speaker:

But, you know, uh, taking the nature of his dark skin, it was really hard to tell

Speaker:

that time if these were bruises or there were insect, uh, like healing insect bites

Speaker:

or maybe a rash of a different etiology.

Speaker:

It's not unusual that we see these dark pigmented, uh, spots in kids,

Speaker:

generally speaking here with dark skin.

Speaker:

But his joint examination was otherwise unremarkable.

Speaker:

But in terms of exposures, um, he does live in a rural area of Oman

Speaker:

in a house with a nearby farm.

Speaker:

But the parents, uh, upon asking them, had mentioned that they couldn't

Speaker:

remember any history of contacts with any animals or cattle or birds,

Speaker:

but they did say that he does get occasional ticks or mosquito bites.

Speaker:

Um, nothing about unpasteurized products that they had taken.

Speaker:

Um, and water source, they usually have like drink from bottles, bottled water.

Speaker:

Um, and there was no history of any recent travel.

Speaker:

His immunization was up to date.

Speaker:

The thing is, we, as you know, we have a really good immunization

Speaker:

program in Oman, and locals tend to really adhere to it, uh, fortunately.

Speaker:

In terms of family history, I would say that, um, there wasn't anything

Speaker:

that was really remarkable except from another, another family member

Speaker:

who also has sickle cell disease.

Speaker:

And in terms of the immunizations, did he get any of those special immunizations

Speaker:

additionally for sickle cell disease, like the pneumococcal vaccine?

Speaker:

Yes.

Speaker:

So, I mean, you know, again, it's integrated as part of what

Speaker:

we have in the health centers.

Speaker:

Um, I'm really proud actually, of our immunization program here.

Speaker:

So yes, he, he, he did.

Speaker:

Um, so Zaid, I mean, take into consideration, you know, that impression

Speaker:

of the septic shock and all this history into account, what infections do you think

Speaker:

would be, uh, a likely cause over here?

Speaker:

I mean, this child is coming in very sick.

Speaker:

He's coming in from the community.

Speaker:

Uh, he's been progressively sick over five days.

Speaker:

You have to think about common things being common.

Speaker:

Um, as you mentioned, they can be susceptible to Streptococcus pneumonia,

Speaker:

um, and salmonella in particular with, with sickle cell disease.

Speaker:

So those would be pretty high on the differential as far as septicemia.

Speaker:

Additionally, other organisms like Staph aureus, Haemophilus influenzae,

Speaker:

Neisseria, should be in consideration.

Speaker:

Cholecystitis can happen in sickle cell disease and maybe that

Speaker:

can, uh, perhaps, uh, predispose to septicemia and bacteremia.

Speaker:

I think although it's, it's looking more like a very acute maybe

Speaker:

bacterial infection, they probably could be a respiratory virus

Speaker:

involved, especially some viruses that have, uh, tropism to the liver.

Speaker:

Since the liver here is uniquely addedly involved.

Speaker:

So I would think about Enteroviruses, adenovirus, influenza, COVID, uh, EBV,

Speaker:

uh, maybe some other herpes viruses, although we don't see specific, uh,

Speaker:

vesicular skin manifestations, like for varicella or herpes simplex?

Speaker:

I think the hepatitis viruses definitely would think about, at

Speaker:

that time that this child presented the Hepatitis A, uh, vaccine hadn't

Speaker:

yet been in the schedule, it is now.

Speaker:

Um, so that was something that we would see from time to time.

Speaker:

Never discount something like HIV as being maybe potentially

Speaker:

part of this, or, or dengue.

Speaker:

And dengue also is mosquito-borne illness.

Speaker:

There's a history here of insect bites.

Speaker:

And at that time, again, dengue was not an issue in, in, in Oman, but now has become

Speaker:

endemic, so now we have to think about it.

Speaker:

So those would be, I think, the most common places to start.

Speaker:

You always have to keep an open mind though for other things,

Speaker:

potentially fungal, although I can't think of much there, maybe

Speaker:

histoplasmosis or uh, atypical bacteria.

Speaker:

Mycoplasma does tend to cause more significant disease and sickle cell

Speaker:

disease and other rickettsia, Brucella, Q fever, tularemia leishmania.

Speaker:

Uh, mycobacterial, TB, parasitic, malaria.

Speaker:

Um, malaria would be, I think, an important differential, although we

Speaker:

don't have much local transmission at all in Oman, usually always,

Speaker:

uh, associated with travel.

Speaker:

But, it can also be always a consideration.

Speaker:

So, uh, besides that, maybe after infection, you, you should think about

Speaker:

maybe some autoimmune diseases, uh uh, or, uh, maybe could this be an unusual

Speaker:

presentation of MIS-C or Kawasaki?

Speaker:

But I think those are less likely possibilities.

Speaker:

Right?

Speaker:

Yes.

Speaker:

Thank you.

Speaker:

So, you know, at that point of time in the emergency department,

Speaker:

we immediately started management.

Speaker:

So, you know, your usual ABCs, oxygen therapy, we gave him a small fluid bolus.

Speaker:

Not too much because we don't want him to go into heart failure when

Speaker:

his hemoglobin is already 2.3.

Speaker:

Um, we started him with small aliquots of blood transfusions.

Speaker:

He got three small aliquots of packed red blood cells and again, small

Speaker:

and slow to avoid heart failure.

Speaker:

Uh, we ended up intubating him, uh, with mechanical ventilation, taking to

Speaker:

consideration, you know, his shocked state, uh, severe lactic acidosis.

Speaker:

His abdomen was quite distended, so, you know, compressing on his lungs.

Speaker:

Um, and also he was in a lot of pain and needed narcotics.

Speaker:

So, you know, that would make him even drowsier.

Speaker:

So he was intubated.

Speaker:

We sent off all the routine labs as well as, you know, those looking for

Speaker:

multiorgan dysfunction, but also, those needed for looking for sepsis,

Speaker:

inflammatory markers, cultures.

Speaker:

Blood, urine, tracheal secretions, you know, taking the fact

Speaker:

that he was initially, um, tachypneic and desaturating.

Speaker:

We sent off the respiratory viral panel, mycoplasma PCR, in some

Speaker:

serologies, as you'd mentioned.

Speaker:

EBV, CMV, HIV, and hepatitis especially because he was jaundiced

Speaker:

and had a tender large liver.

Speaker:

Of course it was started on broad spectrum antimicrobials, so cefotaxime, vancomycin,

Speaker:

and a, a dose of amikacin as well.

Speaker:

And that's when we started getting the lab results back.

Speaker:

Um, his, uh, CBC showed again, confirmed the hemoglobin of 2.3 with

Speaker:

a reticulocytes percentage of 4%.

Speaker:

Um, he had some leukocytosis of 18.6.

Speaker:

Of which 34% were neutrophils, and he was thrombocytopenic, 73,000.

Speaker:

His CRP was quite elevated at almost 350, and his liver

Speaker:

transaminases were quite high.

Speaker:

Um, his ALT was almost a thousand units per liter and

Speaker:

AST was 4,200 right off the bat.

Speaker:

Um, he had hyperbilirubinemia.

Speaker:

Most of it was direct, some hypoalbuminemia 37, not too, too bad.

Speaker:

And he had some coagulopathy.

Speaker:

His INR was 1.6 with D Dimers of 12.9, but his electrolytes and

Speaker:

renal parameters were normal.

Speaker:

His chest x-ray was unremarkable and his abdominal x-ray didn't show any evidence

Speaker:

of perforation or intestinal obstruction.

Speaker:

You know, take into consideration that significant abdominal pain that he had.

Speaker:

So we did a quick bedside echo and it showed that ejection

Speaker:

fraction was about 50%, so, you know, the lower side of normal.

Speaker:

So taking all the above, our findings confirmed that, you know,

Speaker:

our initial thought that this is severe anemia, septic shock.

Speaker:

Um, and he had what, like it looked like hepatic sequestration

Speaker:

with some multiorgan dysfunction.

Speaker:

And we took him for a quick CT, which which actually confirmed the

Speaker:

evidence of hepatic sequestration.

Speaker:

So, um, we took him to the ICU after that.

Speaker:

We worked really hard on him for the first couple of days, and then the next like

Speaker:

24 to 36 hours, you know, by then we had raised his hemoglobin to his baseline.

Speaker:

He, after topping him up, we gave him an exchange transfusion as well to make

Speaker:

sure his hemoglobin S levels were okay.

Speaker:

We made sure he was well volume repleted.

Speaker:

He was already on broad spectrum antimicrobials.

Speaker:

He was on a good amount of sedatives, analgesics.

Speaker:

He was supported with a ventilator and his blood gas is even normalized, but

Speaker:

something was off because we noticed that at that time he was still really, really

Speaker:

tachycardic even when he was afebrile.

Speaker:

And he was still quite vaso constricted and really cold to touch.

Speaker:

And we even started him on milrinone, which is, uh, as intensivist.

Speaker:

We call it an inodilator.

Speaker:

It helps with, uh, inotropy with a contraction, but it

Speaker:

also helps in vasodilating and, you know, warming them up.

Speaker:

Um, we noted that he continued to have high fever, and also his

Speaker:

inflammatory markers continued to rise.

Speaker:

It even reached to 500.

Speaker:

And so, although with the other biochemical profile, like his blood

Speaker:

gases, the electrolytes were all fine, but his clinical picture wasn't still okay,

Speaker:

and something just didn't feel right.

Speaker:

So at that point of time, I picked up the phone and I called my friend from the ID

Speaker:

team Zaid, and I said, you know, Zaid, you know, are we missing out on something?

Speaker:

Should we be investigating for anything else?

Speaker:

Should I be adding another antimicrobial?

Speaker:

I can't put my finger on it.

Speaker:

But I feel something is not right.

Speaker:

So what did you say, Zaid?

Speaker:

Yes, I, I totally agreed at that point.

Speaker:

I remember driving into work that morning and this child was on my mind.

Speaker:

And I went first into the ICU before any morning meetings to see

Speaker:

what is going on with this child, because, uh, he's quite critical.

Speaker:

Uh, he's maintaining his blood pressure, but extremities are

Speaker:

very cold, um, turning dusky.

Speaker:

His laboratory parameters are not really improving and it's only been 24 hours.

Speaker:

But as you said, something really doesn't seem quite right with

Speaker:

this child, and he's very, uh, critical or very worried about him.

Speaker:

Um, I was relatively new as an ID consultant and uh, I was really

Speaker:

starting to panic a little bit.

Speaker:

Um, and, uh, and, um, so at, at this point, you know, we talked

Speaker:

about, uh, atypical causes, like mycoplasma, rickettsia, things

Speaker:

like anaplasmosis and ehrlichiosis, Rocky Mountain Spotted Fever.

Speaker:

These exist in the eastern coast of the United States and the northeast

Speaker:

areas, maybe some other areas as well.

Speaker:

Uh, but, uh, we haven't, we don't see them so much in Oman, but in my

Speaker:

training back in the day, going back to, um, our mentors, Dr. Penelope

Speaker:

Dennehy, uh, she taught us that, you know, you, you gotta think about these

Speaker:

things in such situations, and you gotta also think about empiric doxycycline.

Speaker:

Um, in, in our mind, we, I tried to look around and, call for some help.

Speaker:

Um, and, uh, and there are some atypical bacteria and rickettsia-like,

Speaker:

uh, organisms and, and more things that can involve the liver as well,

Speaker:

and not respond to the usual empiric antibiotics like brucellosis, Q Fever

Speaker:

possibilities for tularemia leishmaniasis.

Speaker:

Maybe syphilis, uh, is, uh, would be quite acute, but unusual presentation for that.

Speaker:

So, I decided to recommend to start empiric doxycycline and also call my good

Speaker:

friend Dr. Badriya from the microbiology lab to help me because we're really

Speaker:

worried about this child and we're not making the progress we'd like to make.

Speaker:

So, Dr. Badriya had some good ideas as well.

Speaker:

Yeah, so I actually bumped into Zaid while I was running to a meeting and,

Speaker:

he expressed his concern about, uh, this child and lots of investigations

Speaker:

were already done and some were already negative and some were still

Speaker:

pending, but nothing positive so far.

Speaker:

So Zaid was particularly concerned about atypical causes,

Speaker:

uh, like he just mentioned.

Speaker:

So we agreed that, uh, we need to do Brucella serology, uh, Q Fever serology,

Speaker:

and because this is an acute presentation, so we thought of acute Q Fever.

Speaker:

So we specifically, uh, wanted a PCR from whole Blood.

Speaker:

So serology and PCR and the PCR we usually send to our reference lab

Speaker:

in Oman, uh, along with, uh, Q fever PCR, they can do also Rickettsia PCR.

Speaker:

So that would be two, uh, in the differential list

Speaker:

of Zaid to be tested for.

Speaker:

And again from the list of differentials.

Speaker:

Uh, Zaid was also still concerned about some viruses, uh, like herpes simplex,

Speaker:

uh, VZV, human herpes virus six.

Speaker:

So PCRs for these were also requested.

Speaker:

Right.

Speaker:

So, um, we added the doxycycline.

Speaker:

It was, um, on day two now, going to day three, uh, for potential zoonosis.

Speaker:

And within 24 hours of initiation, we started seeing an improvement in terms

Speaker:

of the fever pattern, the transaminases.

Speaker:

Um, thereafter the CRP levels started coming down as well, and we were able to

Speaker:

start weaning the supportive measures.

Speaker:

So by day four, the fevers had resolved and, we were off inotropes

Speaker:

and actually extubated, uh, the child, um, thereafter sending him to the ward.

Speaker:

And then during this, uh, period of time, we received a call from a

Speaker:

very smart microbiologist Badriya, with some updates, uh, from the lab.

Speaker:

So, Badriya, would you like to describe them for us?

Speaker:

Yeah, so I actually myself got a phone call as well from the Central Public

Speaker:

Health Lab, telling us that Coxiella burnetti DNA was detected in that

Speaker:

whole blood specimen that we sent.

Speaker:

Uh, it was around, uh, hospital day two it was collected, and, uh, soon after

Speaker:

that we also had the serology result.

Speaker:

So we only do ELISA.

Speaker:

We don't have IFA.

Speaker:

So Coxiella phase two antibodies were positive.

Speaker:

Uh, IGM was strongly positive and IgG was just above the cutoff.

Speaker:

Uh, whereas the phase one antibodies were both negative.

Speaker:

We repeated PCR after two weeks of the child's presentation, and it

Speaker:

was negative, which was reassuring.

Speaker:

We also repeated serology, uh, after two weeks and then again after four weeks.

Speaker:

Phase two antibodies, both IGM and IgG remained positive.

Speaker:

Phase one IgG transiently appeared, uh, at the two week sample, but

Speaker:

then disappeared from the following one, which was again, reassuring.

Speaker:

So, Zaid, uh, would you like to tell us what happened after that?

Speaker:

Yeah.

Speaker:

So the first thing we did is we went back.

Speaker:

So the patient's now doing much better, uh, after a few days of doxycycline.

Speaker:

And then we got this, uh, result about the Q fever.

Speaker:

So the first we go back to the family and say, are you sure there was no animal

Speaker:

exposure and they're like, well, uh, he actually spent likes to spend a lot of

Speaker:

time at grandma's house and she has a bunch of goats in her yard and he helps,

Speaker:

he spent a lot of time with her helping her tend to her goats, and some of them

Speaker:

had given birth recently and all of that.

Speaker:

And like, okay.

Speaker:

So, so that's, that's the, that's the exposure where, where this came from.

Speaker:

Thankfully everything was going very well at this point.

Speaker:

He had been transferred from the ICU to the ward.

Speaker:

The fever resolved for a few days, then started to come back.

Speaker:

But alone, and he was otherwise, everything else was getting

Speaker:

better, and so we kept extending the doxycycline duration.

Speaker:

We did repeat blood cultures, we did the repeat Q fever, coxiella

Speaker:

PCR, and nothing came back positive.

Speaker:

And so after being on doxycycline for three weeks, we decided that

Speaker:

maybe this, uh, fever was, uh, at this point, maybe a drug fever.

Speaker:

We changed azithromycin and then the fever resolved.

Speaker:

And then, after one week of azithromycin, we stopped all of the antibiotics

Speaker:

and he did really well after that.

Speaker:

Um, he recovered essentially fully.

Speaker:

The bilirubin, the albumin, the ALT, they took about three weeks to normalize.

Speaker:

The coagulation profile took about six weeks to, to normalize, and he kept

Speaker:

following up in the hematology clinic and the sickle cell clinic for, uh, we

Speaker:

have, uh, more than two years of follow up since then, and he's done very well.

Speaker:

Um, so he didn't have any kind of chronic complications or chronic infection as far

Speaker:

as we can, we can tell, uh, after that.

Speaker:

So it was a happy ending to a very, uh, tense situation initially.

Speaker:

Yeah, I mean, what an incredible case.

Speaker:

I have not had a case of this, but the best part is hearing that he's doing well.

Speaker:

So maybe we can talk about, what is Q Fever?

Speaker:

I'm sure a lot of us need refreshers and we don't see it that often.

Speaker:

How's it present?

Speaker:

What should we look for?

Speaker:

Um, Zaid, maybe you can tell us about some more info about Q Fever.

Speaker:

Right.

Speaker:

So Q fever, it has this funny name.

Speaker:

It starts with the letter Q, and that apparently comes from query.

Speaker:

So the initial cases were not very clear as far as the etiology.

Speaker:

So they used to call them query fever, and then it became eventually Q Fever.

Speaker:

And then later on the bacteria was discovered, which is a Coxiella burnetii.

Speaker:

It's named after the people who, who discovered it.

Speaker:

Uh, it's an intracellular bacteria.

Speaker:

It's a zoonosis.

Speaker:

The main reservoir are, uh, there, different animals can be the reservoir,

Speaker:

but for as far as human infection, uh, the most significant would be farm animals.

Speaker:

So, cattle, sheep, goats, they tend to get infected with this organism a lot.

Speaker:

Sometimes there can be also outbreaks that can cause kind of abortion outbreaks.

Speaker:

So like in a farm, there can be a lot of abortions all of

Speaker:

a sudden among the animals.

Speaker:

And that could be related to the Coxiella.

Speaker:

So humans who are in close contact with farm animals mostly are the, uh, the

Speaker:

highest risk usually to get infected.

Speaker:

The distribution is quite worldwide, so in the US there are dozens, sometimes

Speaker:

over a hundred cases, uh, in a year.

Speaker:

Australia is another country where, uh, there's usually a lot

Speaker:

of reports, uh, in the Middle East.

Speaker:

We also have a lot of Q fever, uh, and there's a lot of communities and farmers

Speaker:

and people who spend a lot of time with the sheep and with other farm animals.

Speaker:

In Oman, our country specifically, the first case was diagnosed

Speaker:

officially in the year 2000.

Speaker:

So our, our healthcare system was a little bit late to develop,

Speaker:

more like in the 1970s and 1980s.

Speaker:

And so some of these diseases were not recognized by laboratory

Speaker:

confirmation until maybe more recently.

Speaker:

At that time, they did a sero prevalence study, and they found

Speaker:

about 10% of adults were seropositive at that time in our country.

Speaker:

So it's not that, uh, uncommon.

Speaker:

The fever itself, the symptomatic infection, is seen a lot more

Speaker:

in adults than in children.

Speaker:

So children are only about 5% of all of the cases.

Speaker:

Uh, so it tends to be maybe more asymptomatic and self-limited

Speaker:

when occurring in children.

Speaker:

The symptoms usually are a non-specific flu-like illness with fevers and

Speaker:

maybe headaches and body aches.

Speaker:

It can be sometimes presenting as fever of unknown origin.

Speaker:

Uh, it has a tropism for the lungs and for the liver.

Speaker:

So you can see atypical pneumonia.

Speaker:

You can see hepatitis.

Speaker:

Sometimes less commonly, it can be associated with encephalitis

Speaker:

or, or, uh, pericarditis.

Speaker:

Um, in children, the prognosis is usually good, but there are reports

Speaker:

of severe cases, including deaths.

Speaker:

One of the severe manifestations is acute fulminant hepatitis, and, and that's

Speaker:

been described in children and in adults.

Speaker:

There is also in about 1 - 5% patients, there's progression to chronic

Speaker:

infection, and that usually manifests with osteomyelitis, which can be

Speaker:

multifocal and also endocarditis.

Speaker:

And endocarditis usually here happens in the setting of patients who

Speaker:

already have underlying, uh, heart disease like valvular heart disease.

Speaker:

Right.

Speaker:

So, uh, Badriya, As Zaid was just mentioning that, it's through reservoirs

Speaker:

or farm animals, but what is the actual mode of transmission, uh, for Q Fever?

Speaker:

So, transmission to humans occurs mainly through the inhalation of

Speaker:

contaminated aerosols from infected animals or infected environments.

Speaker:

Um, Coxiella is able to survive in the environment for a very long time.

Speaker:

So, even non-direct exposure to animals can still cause, uh, Q Fever and

Speaker:

as Zaid mentioned, birth byproducts like placenta and amniotic fluid.

Speaker:

These particularly have very high numbers of bacteria.

Speaker:

And so exposure to these is a very high risk like this child had.

Speaker:

So he was basically, there at the wrong time.

Speaker:

So he was there in an environment where goats gave birth recently.

Speaker:

Uh, and so I think that's probably the way he got it unfortunately.

Speaker:

There are some other less common modes of transmission, but these are less common.

Speaker:

And some of them are actually rare and some are not even proven.

Speaker:

And these include, uh, percutaneous exposure like for example,

Speaker:

through cuts in the skin while dealing with animal products.

Speaker:

It could also be through ingestion of, for example, unpasteurized milk.

Speaker:

Uh, and possibly it could be tick bone, possibly.

Speaker:

And there has been some rare instances of person to person transmission,

Speaker:

like for example, vertical transmission, sexual, uh, through

Speaker:

transfusion and through transplants.

Speaker:

Yeah, and you know, we talked a little bit about the testing that was sent

Speaker:

for this patient, but maybe Badriya, if you could summarize again for

Speaker:

us, how do we think about screening and confirming this diagnosis,

Speaker:

particularly since it's so uncommon.

Speaker:

Right.

Speaker:

So, so to start with, uh, you know, a disclaimer, uh,

Speaker:

I'm not an expert in Q Fever.

Speaker:

Maybe we should have invited somebody from Australia to go through this.

Speaker:

The CDC has actually published, uh, a very useful document in 2013, and I

Speaker:

always go back, uh, to that document.

Speaker:

It's basically describes the diagnosis and the management of Q Fever.

Speaker:

And it also provides criteria for labeling a case as confirmed or as probable.

Speaker:

So in general, when it comes to testing for Q Fever, testing basically aims

Speaker:

to either detect the organism itself, and that would be mostly by PCR.

Speaker:

But there are some other methods like, for example, culture.

Speaker:

Uh, which is generally not recommended as it is difficult and it has,

Speaker:

you know, exposure risk, and, uh, there's also immunohistochemistry.

Speaker:

Uh, so this allows us to detect the organism.

Speaker:

The other way is to detect the antibodies against the organism,

Speaker:

so that would be using serology.

Speaker:

And the best method would be by indirect immunofluorescence assay, because that

Speaker:

actually provides titers and titers are very important in the diagnosis

Speaker:

of Q Fever because, for example, a confirmed acute case of Q Fever requires

Speaker:

either the detection of Coxiella in a clinical sample, or, the demonstration

Speaker:

of a fourfold rise in phase two IgG titers between paired serum that are

Speaker:

collected three to six weeks apart.

Speaker:

For, uh, chronic Q Fever, again, laboratory confirmation requires either

Speaker:

the detection of the organism in a clinical sample or the demonstration

Speaker:

of antibodies, but this time against phase one antigens that goes with

Speaker:

chronic Q fever and the titers that are diagnostic are more than or equal to 800.

Speaker:

Uh, or if using doubling dilution, it'll be, uh, 1024.

Speaker:

So, in our lab, as I have mentioned earlier, we use ELISA,

Speaker:

which does not provide titers.

Speaker:

However, fortunately because we managed to catch the organism on time and we

Speaker:

managed to get a positive PCR result, this was a confirmed case by definition.

Speaker:

Yeah.

Speaker:

And you know, thinking about the other features about this case that are a bit

Speaker:

unique is, um, this patient's history of sickle cell disease and I thought maybe

Speaker:

I'd ask about this concept of acute sickle hepatopathy and and what that means.

Speaker:

Right.

Speaker:

So the, this case was very fascinating because of the presence of the

Speaker:

sickle cell disease, the severe liver involvement, and then the Q fever.

Speaker:

So we really looked at the literature to see what is there about sickle

Speaker:

cell disease and Q fever, and actually we couldn't find any case

Speaker:

of Q fever reported in the setting of sickle cell disease itself.

Speaker:

So it's very fascinating in case this one, showing like the

Speaker:

intersection of these two diseases.

Speaker:

Uh, so, but acute sickle hepatopathies, this is an entity that's quite

Speaker:

known in patients with sickle cell disease, some studies estimate

Speaker:

that up to 10% of patients with vaso-occlusive crisis can have, uh,

Speaker:

hepatopathy or liver involvement.

Speaker:

It actually, they're quite dangerous.

Speaker:

So there can be, the mortality in some studies can be 11 to

Speaker:

14% in, in adults, uh, probably lower in children, thankfully.

Speaker:

There are different types of acute sickle hepatopathy.

Speaker:

So, the first one is, uh, thought to be the, uh, hepatic crisis, uh,

Speaker:

which is basically vaso-occlusive crisis involving the liver.

Speaker:

There, there would be some tender hepatomegaly, elevated liver

Speaker:

enzymes, fever, and mild jaundice.

Speaker:

But it's not very severe presentation.

Speaker:

Uh, but the next is what we started to see in our patient is hepatic sequestration.

Speaker:

And here there's sequestration within the sinusoids of the, of

Speaker:

the liver and, and, and there you get very massive hepatomegaly.

Speaker:

It's very tender and you get severe anemia and you start to see direct

Speaker:

hyperbilirubinemia, but the liver transminases are not yet severely

Speaker:

elevated and maybe the most severe form, probably progressing from there

Speaker:

is intra hepatic cholestasis, where then you have all of the previous findings

Speaker:

plus the, uh, marked elevation of the transaminases and progressive liver

Speaker:

failure, which is what we started to, which we we're seeing in in our patients.

Speaker:

And so, so what we think happened here is that the, the Coxiella having

Speaker:

the hepatic tropism probably caused this liver inflammation, and that

Speaker:

triggered maybe the more sickling of the red blood cells in the sinusoids

Speaker:

leading to hepatic sequestration, which then leads to maybe sinusoidal

Speaker:

dilatation, compression of the biliary tree, and intrahepatic cholestasis.

Speaker:

That's, you know, our hypothesis of the, of the process.

Speaker:

These acute sickle hepatopathies are well described with a lot of

Speaker:

other infectious agents, especially those that affect the liver, like

Speaker:

hepatitis viruses and Epstein-Barr virus and even autoimmune disease.

Speaker:

Uh, they can happen.

Speaker:

But with Q Fever, this seems to be for us as, as far as we could

Speaker:

tell, this was the first report.

Speaker:

We also looked at maybe other Rickettsia.

Speaker:

Well, Q fever is not exactly a rickettsia disease.

Speaker:

It's a category of its own, but it's related, uh, they're kind of

Speaker:

like cousins with rickettsia and legionella, if you could say, um.

Speaker:

So we, we did find there was some cases of uh, anaplasmosis, uh,

Speaker:

there's one case of anaplasmosis and hemoglobin SC that was quite

Speaker:

severe, presented multi-organ failure.

Speaker:

Uh, but besides that, I suppose there could be some similar presentations with

Speaker:

ricketssial disease or maybe anaplasmosis or, or any hepatotropic basically,

Speaker:

uh, bacteria or infectious agent could present with acute sickle hepatopathy.

Speaker:

So that was a very, uh, unique and fascinating aspect to, to this case.

Speaker:

And, uh, and we could be at, at least happy that the child had

Speaker:

a very good recovery, although we were really worried about him

Speaker:

at, at, at the time he presented.

Speaker:

Yeah.

Speaker:

Well, I always like to wrap up by opening it up just to ask if

Speaker:

you have any additional comments or lessons that you've learned.

Speaker:

You've been really great at pointing out things that stood out to you as we went,

Speaker:

but anything else you'd like to add?

Speaker:

Well, I mean, I would say is that, you know, whenever the clinical course

Speaker:

doesn't go as expected, sometimes you get this gut feeling, even if

Speaker:

you can't put your finger on it.

Speaker:

You know, think again, go back to the beginning, you know, what did we miss?

Speaker:

And don't hesitate to call up a friend and ask for help.

Speaker:

You know, different specialties, just putting their heads together and

Speaker:

trying to come up with a solution.

Speaker:

From my side, I have to say that I really admired, um, Zaid's perseverance and

Speaker:

he went back and actually asked again about the exposure history, even though

Speaker:

he got a no, no, no, the first time.

Speaker:

Uh, but you know, he went again and he asked again.

Speaker:

So, uh, I really admired that and.

Speaker:

Another thing I would add is sometimes you really have to seize

Speaker:

the moment, like they say, and catch the organisms at the right time.

Speaker:

So I'm really glad that we got that first sample for Coxiella PCR, because

Speaker:

it soon disappears after that, and it did actually disappear after two weeks.

Speaker:

And since we don't have IFA, our ELISA wouldn't have been diagnostic.

Speaker:

Uh, but we caught it at the right time.

Speaker:

So I'm glad we did that.

Speaker:

From my, uh, point, uh, of view.

Speaker:

So one, one thing that was interesting about this case,

Speaker:

why did we send the Q fever PCR?

Speaker:

And I was like, um, running around the hospital, worried about this patient,

Speaker:

and, different people would offer their ideas as to what's going on.

Speaker:

And one of the residents, he stood in front of me and said,

Speaker:

have you thought about Q Fever?

Speaker:

And I'm like, why?

Speaker:

Why are you thinking about Q Fever?

Speaker:

And apparently he had seen some cases in, in adults, like in

Speaker:

adult in medicine rotations.

Speaker:

Uh, and, and that got me like reading about it.

Speaker:

I asked Badriya about it and she's like, yeah, we can send a PCR, I,

Speaker:

because I, I never seen a case before.

Speaker:

It's not very common in children and we just read about it in textbooks.

Speaker:

Like it, uh, it's very rare to see the actual symptomatic case in a child,

Speaker:

and so, uh, thankfully I had the humility to listen to the resident and

Speaker:

go with that and, you know, so I think that's very important to, to listen

Speaker:

to people even as we progress in our career, to always listen to everyone

Speaker:

and take their ideas very seriously.

Speaker:

And I think that another important point here, empiric doxycycline sometimes when

Speaker:

things are looking unusual atypical.

Speaker:

Um, I think it saved this child's life.

Speaker:

Uh, and in fact, if anything, I would say maybe we start a little

Speaker:

bit late on the second day.

Speaker:

Maybe we could have even started earlier with the empiric doxycycline.

Speaker:

So, uh, that's I think another important lesson here.

Speaker:

Uh, so yeah and thank god for microbiologists, right?

Speaker:

Thanks so much to our guests today for joining Febrile.

Speaker:

Don't forget to check out the website febrilepodcast.com where

Speaker:

we post the Consult Notes, which are written supplements of the

Speaker:

episodes with links to references, our library of ID infographics,

Speaker:

and a link to our merch store.

Speaker:

Febrile is produced with support from the Infectious Diseases Society of America.

Speaker:

Please reach out if you have any suggestions for future shows or

Speaker:

wanna be more involved with Febrile.

Speaker:

Thanks for listening.

Speaker:

Stay safe and I'll see you next time.

Chapters

Video

More from YouTube